InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MHZ | Ann: Removal from Official List | 09/08/11 | 0 | 191 | |||
|
|||||||
MHY +MHZ | Ann: Appointment of Voluntary Administrators | 14/12/09 | 0 | 241 | |||
|
|||||||
MHZ | Ann: Update on Valuations and Voluntary Administr | 14/12/09 | 0 | 166 | |||
|
|||||||
MHZ | Ann: Update on UK Legal Proceedings | 12/11/09 | 0 | 184 | |||
|
|||||||
MHZ | Ann: Perpetual action in respect of series accoun | 09/10/09 | 0 | 150 | |||
|
|||||||
MHZ | Ann: Perpetual Trustee as controller of Saphir I | 29/09/09 | 0 | 157 | |||
|
|||||||
MHZ | Ann: Annual Financial Report | 28/09/09 | 0 | 115 | |||
|
|||||||
MHZ | Ann: Mahogany Capital Limited - additional letter | 31/08/09 | 0 | 170 | |||
|
See All Discussions